This Subcontract opportunity from Department Of Defense was posted on August 30, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Manufacture and Supply of Dextrose Injection 5%, USP

Closed

Federal

Submission Closed09/08/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

BISMUTH SUBSALICYLATE

Solicitation # SPE2DP-27-T-0266

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Assayed Liquid Human Serum Comprehensive Chemistry Control SupplyThis subcontract involves the supply of assayed liquid human serum-based comprehensive chemistry control for prime contractors supporting Department of Defense DLA Troop Support Medical Supply Chain projects. The requirement is for 84 units of frozen diagnostic control material, specifically Level 3 control featuring over 50 analytes. All materials must have a minimum shelf life of 24 months and be packaged according to Medical Marking Standard No. 1. To ensure product integrity, the contractor must maintain a strict cold chain storage environment between -20 and -70 degrees Celsius. The performance of this contract will take place in APO 09227. This opportunity falls under NAICS code 325412 and is managed by the Medical Supply Chain MD SURG FSF.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Antiseptic Prep Swab SupplierThis subcontract opportunity is for a supplier to manufacture and provide pre-saturated antiseptic swabs to prime contractors supporting Department of Defense medical supply chain projects. The scope of work includes the production of alcohol and Povidone-iodine prep swabs utilizing medical-grade applicators. All products must be individually wrapped, delivered in bulk quantities, and maintain FDA approval for medical-grade antiseptics with a guaranteed stability supporting a 36-month shelf life. Managed by the Medical Supply Chain MD Surg FSF, the contract is associated with NAICS code 325412 and specifies San Antonio as the place of performance. Interested parties must submit their responses by November 16, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Hand Sanitizer (70% Ethyl Alcohol) SupplyThis subcontract involves the supply of unscented, waterless hand cleanser for prime contractors supporting the Department of Defense Medical Supply Chain. The requirement is for four packages of 70% ethyl alcohol base cleanser, with each package containing twenty-four 4 fl oz bottles. All products must adhere to Medical Marking Standard No. 1 and MIL-STD-2073-1E, ensuring a 36-month shelf life with no more than five months elapsed upon delivery. The contract is categorized under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF. Performance for this contract will take place in Annville, Pennsylvania. Interested parties should note the response deadline of November 16, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Sterile Medical Kitting and PackagingThis subcontract for Sterile Medical Kitting and Packaging supports prime contractors on DLA supply contracts for the Department of Defense Medical Supply Chain. The scope of work involves the assembly of instruments into kits, sterilization for single-use disposable requirements using industrial autoclaves, and final packaging. All deliverables must be marked according to Medical Marking Standard No. 1 and MIL-STD-2073-1E to ensure the delivery of completed, sterile, and sealed Dental Operative Kits. The project falls under NAICS code 325412 and is performed at a facility in FPO 34088-3000. Interested parties should note the response deadline of November 16, 2026, following the posting date of November 8, 2026.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Levonorgestrel and Ethinyl Estradiol Tablets SupplyThis subcontract involves the supply of finished pharmaceutical tablets containing Levonorgestrel and Ethinyl Estradiol for prime contractors supporting Department of Defense DLA Troop Support Medical Supply Chain projects. The contractor is responsible for manufacturing or sourcing tablets that adhere to USP standards, ensuring precise dosage sequencing and a minimum shelf life of 21 months. All production must occur in FDA-approved facilities, and products must be maintained in temperature-controlled storage between 20 and 25 degrees Celsius. Deliverables consist of 168-tablet packages that comply with Medical Marking Standard No. 1A and MIL-STD-129. This opportunity falls under NAICS code 325412 and was posted on November 8, 2026, with a response deadline of November 16, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Albuterol Sulfate Tablets (4 mg)This subcontract opportunity through the Department of Defense Medical Supply Chain Pharm FSA involves the procurement of 3,000 bottles of Albuterol Sulfate Tablets (4 mg). The selected provider must manufacture or source tablets that strictly adhere to NSN 6505011388028 specifications. To be eligible, candidates must hold status as a qualified pharmaceutical manufacturer or an authorized distributor. The contract mandates the use of commercial packaging and packing standards, specifically requiring sealed unit containers to prevent damage and commercial exterior shipping containers suitable for common carrier delivery. Interested parties must submit their responses by November 16, 2026, under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Veterinary Enrofloxacin Injection SupplierThis subcontract involves the supply of FDA-regulated Enrofloxacin Injection for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The requirement is for 10 units of an intramuscular solution for dogs with a concentration of 2.27 percent and a dosage of 2.5mg/kg in 20ml volumes. All products must be produced in FDA-approved manufacturing facilities and maintain a non-extendable shelf life of 24 months. Strict adherence to Medical Marking Standard No. 1 is required, and the product must be kept in temperature-controlled storage at or below 25 degrees Celsius. The performance location for this contract is listed as APO 09227-0000. Interested parties must respond by November 16, 2026, under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ENROFLOXACIN INJECTION

Solicitation # SPE2DP-27-T-0263

Solicitation SPE2DP-27-T-0263 is a small business set-aside request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of 10 units of Enrofloxacin Injection, Veterinary. The product is an intramuscular solution for dogs (2.27%, 2.5mg/kg, 20ml) used to manage bacterial pathogens. This FDA-regulated drug has a non-extendable shelf life of 24 months and must be stored at or below 25 degrees Celsius, protected from direct sunlight and freezing, with permitted excursions up to 40 degrees Celsius. Delivery is required FOB Destination to the USA Med Mat Ctr EUR in Kaiserslautern, Germany, with a delivery window of 81 days after order. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging must follow MIL-STD-2073-1E using suitable sealed unit and commercial exterior containers. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses, including those regarding hazardous material identification, the Buy American Act, and prohibitions on the use of mandatory arbitration agreements. The primary point of contact for this acquisition is Shairy M. Cartagena.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0259

Solicitation SPE2DP-27-T-0259 is a small business set-aside procurement issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the supply of surgical detergent containing 4% chlorhexidine gluconate. The requirement is for one 8 oz bottle (NSN 6505-01-101-3759) to be delivered FOB Destination to the USNS City of Bismarck by November 10, 2026. The item is classified as a Type I (Code M) product with a non-extendable shelf life of 24 months, and it must have at least 21 months of shelf life remaining upon delivery to the government. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers. Marking and labeling must strictly adhere to Medical Marking Standard No. 1 and 1C, which supersedes MIL-STD-129. If the material is deemed hazardous per FED-STD-313, it must be packaged according to TQ requirement IP025; otherwise, ASTM D3951 applies. The contract incorporates various federal regulations, including the Buy American and Balance of Payments Program, DFARS cybersecurity reporting requirements, and the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and receiving reports. Inspection and acceptance will occur at the destination per FAR 52.246-2.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

APPLICATOR, SILVER NITR

Solicitation # SPE2DP-27-T-0261

This procurement is for the supply of silver nitrate applicators, which are FDA-regulated, prescription-only devices for topical use. Each applicator consists of a mixture of 75% silver nitrate and 25% potassium nitrate fused to one end measuring 6 inches. The unit of issue is a container of 100 applicators, and the contract requires a total quantity of 2 containers. These items must be stored in closed packaging at room temperature in a dark, dry location away from oxidizable materials. The product has a non-extendable shelf life of 24 months. The contract is a small business set-aside with a delivery timeline of 20 days after the order, shipping FOB Destination to the USS SANTA BARBARA. Due to the hazardous nature of the materials, the contractor must provide a current Material Safety Data Sheet (MSDS) with each shipment and ensure packaging complies with 49 CFR and ICAO or IMDG requirements. All shipments must be marked according to MIL-STD-129 and Medical Marking Standard No. 1. Payment and receiving reports are to be processed electronically via the Wide Area WorkFlow (WAWF) system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

AMLODIPINE BESYLATE TA

Solicitation # SPE2DP-27-T-0264

Solicitation SPE2DP-27-T-0264, issued by the Defense Logistics Agency, is a small business set-aside for the procurement of 3 bottles of Amlodipine Besylate Tablets (5mg, 300s). The contract specifies a strict delivery timeline of 5 days after order and requires that no more than 21 months have elapsed from the date of manufacture to the date of government delivery. The product must be stored at a controlled room temperature between 15-30 degrees Celsius and is regulated by the FDA. Delivery is established as FOB Destination, with both inspection and acceptance occurring at the destination per FAR 52.246-2. Packaging must adhere to MIL-STD-2073-1E and special instructions MPPWN00001, utilizing commercial exterior shipping containers and sealed unit containers. Marking must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and payments, and compliance with DFARS cybersecurity and Buy American regulations.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 7 days

AI Contract Overview

This subcontract involves the manufacture and supply of sterile Dextrose Injection 5% for prime contractors supporting the Defense Logistics Agency medical supply chain. The scope of work includes compounding Hydrous Dextrose USP with Water for Injection USP, filling 1,000 ML containers, and performing sterilization and quality testing to ensure full USP compliance. All production must occur within an FDA-approved facility using pharmaceutical-grade equipment. The contractor is responsible for delivering finished, packaged containers that adhere to DLA RP001 packaging standards. This requirement falls under NAICS code 325412 and is managed by the Department of Defense Medical Supply Chain Pharm FSA. The performance location is designated as FPO 09592-1200, with a response deadline of September 8, 2026.

General Info

Manufacture and supply sterile Dextrose Injection 5% for DLA by September 8, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

FPO, AE, 09592-1200, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-26-T-4789.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

DEXTROSE INJECTION,

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed

PostedAug 30

subcontract

Response DeadlineSep 8

Deadline has passed

Submission Closed

09/08/2026, 05:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressN/A

ContactsNo contact information available

Full Description

Manufactures and supplies sterile Dextrose Injection 5% for prime contractors on Defense Logistics Agency (DLA) medical supply contracts. Compounds Hydrous Dextrose USP with Water for Injection USP, performs sterilization and filling of 1,000 ML containers, and conducts quality testing for USP compliance. Uses pharmaceutical-grade mixing and sterilization equipment. Requires FDA-approved facility and DLA RP001 packaging compliance. Delivers finished, packaged containers.